Continuous glucose monitoring reduces both hypoglycaemia and HbA1c in hypoglycaemia-prone type 1 diabetic patients treated with a portable pump;L'apport d'une mesure continue du glucose réduit le taux d'HbA1c et la fréquence des hypoglycémies chez des patients diabétiques de type 1 traités par pompe portable à insuline et à risque hyp

Diabetes and Metabolism

Volumn 36, Issue 5, 2010, Pages 409-413

  Radermecker, R P ^a   Saint Remy, A ^a   Scheen, A J ^a   Bringer, J ^b   Renard, E ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CNRS   (France)

Author keywords

Continuous glucose monitoring; Hypoglycaemia; Insulin pump; Quality of life; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS INFUSION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; PILOT STUDY; QUALITY OF LIFE;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN INFUSION SYSTEMS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 78649446226     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.08.001     Document Type: Article

References (18)

1. Cryer P.E. Hypoglycaemia: the limiting factor in the management of type 1 and type 2 diabetes. Diabetologia 2002, 45:937-948.
2. Jeitler K., Horvath K., Berghold A., Gratzer T.W., Neeser K., Pieber T.R., et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008, 51:941-951.
3. Pickup J.C., Sutton A.J. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008, 25:765-774.
4. Radermecker R.P., Scheen A.J. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life and cost-effectiveness. Diabetes Metab Res Rev 2004, 20:178-188.
5. Larsen J., Ford T., Lyden E., Colling C., Mark-Shipman L., Lane J. What is hypoglycemia in patients with well-controlled type 1 diabetes treated by subcutaneous insulin pump with use of the continuous glucose monitoring system?. Endocr Pract 2004, 10:324-329.
6. Hirsch I., Armstrong D., Bergenstal R.M., Buckingham B., Childs B.P., Clarke W.L., et al. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther 2008, 10:232-246.
7. Hirsch I.B., Abelseth J., Bode B.W., Fischer J.S., Kaufman F.R., Mastrototaro J., et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008, 10:377-383.
8. Thielen V., Place J., Gerbaud S., Scheen A., Bringer J., Renard E. Education on sensor-augmented pump use improves glucose control in type-1 diabetic patients. Diabetes Metab 2010, 36:170-171.
9. Garg S., Zisser H., Schwartz S., Bailey T., Kaplan R., Ellis S., et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006, 29:44-50.
10. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005, 28:1245-1249. Workgroup on Hypoglycemia. American Diabetes Association.
11. Gill G.V., Woodward A., Casson I.F., Weston P.J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited. Diabetologia 2009, 52:42-45.
12. Rubin R.R., Peyrot M. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump. J Diabetes Sci Technol 2009, 3:1402-1410.
13. Renard E., Apostol D., Lauton D., Boulet F., Bringer J. Quality of life in diabetic patients treated by insulin pumps. QOL Newsl 2002, 28:11-13.
14. Pickup J.C., Kidd J., Burmiston S., Yemane N. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 2006, 22:232-237.
15. Bode B.W. Clinical utility of the continuous glucose monitoring system. Diabetes Technol Ther 2000, 2(Suppl. 1):S35-S41.
16. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008, 359:1873-1884. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.
17. Raccah D., Sulmont V., Reznik Y., Guerci B., Renard E., Hanaire H., et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care 2009, 32:2245-2250.
18. Choudhary P., Geddes J., Freeman J.V., et al. Frequency of biochemical hypoglycaemia in adults with Type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring. Diabet Med 2010, 27:666-672.